SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Federal Reserve Balance Sheet Reduction: Brookings Research Outlines Possible Path Forward 
Currency Markets Show Caution Amid U.S.-Iran Negotiations 
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave 
Gold is meant to be a ‘safe haven’ in uncertain times. Why is it crashing amid a war? 
Bank of Japan Officials Signal Continued Interest Rate Hikes Amid Inflation Concerns 
Oil Prices Climb as Iran Reviews U.S. Peace Proposal Amid Middle East Tensions 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
Sonova Shares Slip as Hearing Aid Giant Lowers Growth Outlook and Plans Sennheiser Exit 
Is dark chocolate healthier than milk chocolate? 2 dietitians explain 
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain 
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets 
South Korea will invest 274.6 billion won in the bio-industry this year for 252 new R&D projects in the four fields of biopharmaceuticals, healthcare, biomaterials, and medical equipment in 2023.
According to South Korea’s Ministry of Trade, Industry and Energy, 94.8 billion won would be allocated to developing new medicines, microbiome analysis, and other biomanufacturing process technology.
Around 69.5 billion won will support the development of advanced medical appliances, and 30 billion won will be for developing state-of-the-art biomaterials.
The ministry added that beefing up support for biomaterials and other new fields of the sector would promote innovation.
